Intrexon reported $36.41M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 336.2M 119.31M
Adamas Pharmaceuticals ADMS:US 88.8M 36.03M
Agenus AGEN:US $ 73.54M 45.82M
Amgen AMGN:US $ 6630M 518M
Anika Therapeutics ANIK:US $ 97.18M 2.58M
Arrowhead Research ARWR:US $ 325.98M 46.4M
AstraZeneca AZN:LN 15567M 7931M
Bluebird Bio BLUE:US $ 353.47M 86.25M
Bristol Myers Squibb BMY:US $ 13540M 2516M
Chemocentryx CCXI:US $ 77.2M 8.66M
Dicerna Pharmaceuticals DRNA:US $ 221.21M 62.1M
Flexion Therapeutics FLXN:US $ 107.63M 8.92M
Gilead Sciences GILD:US $ 4893M 828M
GlaxoSmithKline GSK:LN 3453M 50M
Heron Therapeutics HRTX:US $ 191.17M 131.43M
Immunogen IMGN:US $ 239.54M 43.58M
Intrexon XON:US $ 36.41M 9.06M
Karyopharm Therapeutics KPTI:US $ 141.31M 52.84M
Ligand Pharmaceuticals LGND:US $ 301.83M 269.98M
Macrogenics MGNX:US $ 188.97M 29.53M
Mannkind MNKD:US $ 62.52M 185.31M
Merk MRK:US $ 8575M 1594M
Novartis NOVN:VX SF 5117M 1316M
Peregrine Pharmaceuticals PPHM:US $ 159.69M 10.22M
Rigel Pharmaceuticals RIGL:US $ 84.82M 64.78M
Sangamo Biosciences SGMO:US $ 169.88M 46.9M
Thermo Fisher Scientific TMO:US $ 12027M 5004M
Veracyte VCYT:US $ 327.54M 3.48M
Xencor XNCR:US $ 115.84M 61.12M
YTE INCY:US $ 1797.58M 127.61M
Ziopharm Oncology ZIOP:US $ 76.75M 23.31M